Data layers Raw facts Calculated Model prediction AI interpretation

Company Overview

Stock NameWuxi XDC
Stock Code02268
Company Full NameTo be extracted
Industry醫療保健
Principal Activities公司是專注于全球ADC及更廣泛生物偶聯藥物市場的領先CRDMO,亦是一家致力于提供全面綜合服務的公司。
Listing Date2023-11-17
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國江蘇省無錫市新吳區新輝環路11號
Business Address (Hong Kong)To be extracted
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitehttps://wuxixdc.com/
Share Registrar香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited)
Registrar Contact(852)2862 8628
A-Share/US Dual ListingNo data

Offering Information

Offering Mechanism To be extracted
Offer PriceHK$ 20.60 / shares
Offer Price RangeTo be extracted
Lot SizeTo be extracted
Entry ThresholdTo be extracted
Par ValueTo be extracted
Offer PeriodTo be extracted
Global Offering SharesTo be extracted
HK Public Offer Shares (Initial)To be extracted
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)To be extracted
Offer RatioTo be extracted
Total Shares Post-IPOTo be extracted
Greenshoe (Over-allotment Option)To be confirmed
Stabilizing Manager (Greenshoe)—
Cornerstone Share63.8%
Clawback TiersTo be extracted
Reallocation OptionTo be confirmed
Total Global Offering SizeHK$ 1,102,800,400

Subscription Tiers

Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.

Pool A
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1 lots 500 HK$ 10,300
2 lots 1,000 HK$ 20,600
3 lots 1,500 HK$ 30,900
4 lots 2,000 HK$ 41,200
5 lots 2,500 HK$ 51,500
6 lots 3,000 HK$ 61,800
7 lots 3,500 HK$ 72,100
8 lots 4,000 HK$ 82,400
9 lots 4,500 HK$ 92,700
10 lots 5,000 HK$ 103,000
12 lots 6,000 HK$ 123,600
14 lots 7,000 HK$ 144,200
16 lots 8,000 HK$ 164,800
18 lots 9,000 HK$ 185,400
20 lots 10,000 HK$ 206,000
30 lots 15,000 HK$ 309,000
40 lots 20,000 HK$ 412,000
50 lots 25,000 HK$ 515,000
60 lots 30,000 HK$ 618,000
70 lots 35,000 HK$ 721,000
80 lots 40,000 HK$ 824,000
90 lots 45,000 HK$ 927,000
100 lots 50,000 HK$ 1,030,000
120 lots 60,000 HK$ 1,236,000
140 lots 70,000 HK$ 1,442,000
160 lots 80,000 HK$ 1,648,000
180 lots 90,000 HK$ 1,854,000
200 lots 100,000 HK$ 2,060,000
250 lots 125,000 HK$ 2,575,000
300 lots 150,000 HK$ 3,090,000
350 lots 175,000 HK$ 3,605,000
400 lots 200,000 HK$ 4,120,000
450 lots 225,000 HK$ 4,635,000
Pool B
Lots SubscribedShares SubscribedSubscription Amount (HKD)
500 lots 250,000 HK$ 5,150,000
1,000 lots 500,000 HK$ 10,300,000
1,500 lots 750,000 HK$ 15,450,000
2,000 lots 1,000,000 HK$ 20,600,000
4,000 lots 2,000,000 HK$ 41,200,000
6,000 lots 3,000,000 HK$ 61,800,000
8,000 lots 4,000,000 HK$ 82,400,000
10,000 lots 5,000,000 HK$ 103,000,000
12,000 lots 6,000,000 HK$ 123,600,000
14,000 lots 7,000,000 HK$ 144,200,000
17,845 lots 8,922,500 HK$ 183,803,500
187,679 lots 93,839,657 HK$ 1,933,096,934

Stock Connect Inclusion Analysis

Avg Daily HK Mkt Cap ---
Analysis Result Already included in Stock Connect (both)

Valuation & Financials

Market Cap (at Offer Price)To be extracted
Pre-IPO Valuation (Last Round)Not disclosed
P/E RatioNot disclosed
Profit/Loss StatusTo be extracted
Period-End Cash BalanceTo be extracted
Listing ExpensesTo be extracted
Listing Expenses / Funds RaisedTo be extracted
Total Pre-IPO InvestmentTo be extracted
First Day CloseHK$ 2.52
First Day OpenHK$ 2.3
First Day Change-2.30%
First Day Volume66988000.0
First Day Turnover159746000.0
Use of Proceeds
1、約67%或2,333.8百萬港元將用于(i)在新加坡興建我們的設施及(ii)擴大我們在中國的服務實力及能力,以進一步擴大服務實力及能力; 2、約23%或801.2百萬港元將用于有選擇地尋求戰略聯盟、投資及收購機會,主要旨在擴大技術平臺及服務類型和能力; 3、約10%或348.3百萬港元用作營運資金及其他一般公司用途。

Underwriting Syndicate

Joint Sponsors (3)
Morgan Stanley Asia Limited CE AAD291 GOLDMAN SACHS (ASIA) L.L.C. CE ACC536 J.P. Morgan Securities (Far East) Limited CE AAB026
Overall Coordinators (6)
Morgan Stanley Asia Limited CE AAD291 GOLDMAN SACHS (ASIA) L.L.C. CE ACC536 J.P. Morgan Securities (Asia Pacific) Limited CE AAJ321 中国国际金融香港证券有限公司 CE AEN894 Citigroup Global Markets Asia Limited CE AAA137 HUATAI FINANCIAL HOLDINGS (HONG KONG) LIMITED CE AOK809
Joint Bookrunners (6)
Morgan Stanley Asia Limited CE AAD291 GOLDMAN SACHS (ASIA) L.L.C. CE ACC536 J.P. Morgan Securities (Asia Pacific) Limited CE AAJ321 中国国际金融香港证券有限公司 CE AEN894 Citigroup Global Markets Asia Limited CE AAA137 HUATAI FINANCIAL HOLDINGS (HONG KONG) LIMITED CE AOK809
Joint Lead Managers (6)
Morgan Stanley Asia Limited CE AAD291 GOLDMAN SACHS (ASIA) L.L.C. CE ACC536 J.P. Morgan Securities (Asia Pacific) Limited CE AAJ321 中国国际金融香港证券有限公司 CE AEN894 Citigroup Global Markets Asia Limited CE AAA137 HUATAI FINANCIAL HOLDINGS (HONG KONG) LIMITED CE AOK809

Cornerstone Investors

#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 Al-Rayyan Holding LLC 351,981,900 HKD — 9.58% — 6 months 2024-05-17
2 General Atlantic Singapore SPV 64 Pte. Ltd. 391,091,000 HKD — 10.64% — 6 months 2024-05-17
3 HongShan Funds 234,654,600 HKD — 6.38% — 6 months 2024-05-17
4 Invesco Advisers, Inc. 782,182,000 HKD — 21.28% — 6 months 2024-05-17
5 Lake Bleu Prime Healthcare Master Fund Limited 78,218,200 HKD — 2.13% — 6 months 2024-05-17
6 Novo Holdings A/S 195,545,500 HKD — 5.32% — 6 months 2024-05-17
7 UBS Asset Management (Singapore) Ltd. 312,872,800 HKD — 8.51% — 6 months 2024-05-17

Directors & Management

PositionChinese nameEnglish Name
Chairman陳智勝—
Company Secretary席曉捷—
No director data available.

Major Shareholders

Major Shareholders & Holdings藥明生物技術有限公司(50.91%);合全藥業香港投資有限公司(33.94%)
About this page

This page shows Wuxi XDC (02268) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect